- €773.89m
- €1.11bn
- €427.97m
- 34
- 84
- 54
- 60
2019 December 31st | C2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 136 | 136 | 139 | 157 | 249 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 117 | 111 | 107 | 131 | 210 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 103 | 84.9 | 96.2 | 78.6 | 206 |
Provision for Income Taxes | |||||
Net Income After Taxes | 92.9 | 74.8 | 83.3 | 63.6 | 179 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 92.9 | 74.8 | 83.3 | 63.6 | 179 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 92.9 | 74.8 | 83.3 | 63.6 | 179 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.21 | 1.78 | 1.98 | 1.51 | 4.04 |
Dividends per Share |